• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PYK2 通过稳定 TAZ 蛋白负调控三阴性乳腺癌中的 Hippo 通路。

PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein.

机构信息

Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, 76100, Israel.

Center for Bioinformatics and Computational Biology, University of Maryland, College Park, MD, 20742, USA.

出版信息

Cell Death Dis. 2018 Sep 24;9(10):985. doi: 10.1038/s41419-018-1005-z.

DOI:10.1038/s41419-018-1005-z
PMID:30250159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6155151/
Abstract

The tumor suppressor Hippo pathway negatively regulates the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) to inhibit cell growth and control organ size, whereas activation of YAP and TAZ is implicated in tumorigenesis and cancer metastasis. Here, we report that the nonreceptor tyrosine kinase PYK2 positively regulates TAZ and YAP transcriptional activity in triple-negative breast cancer (TNBC). We found that inhibition of PYK2 expression or its kinase activity substantially affects the steady-state level of TAZ and markedly facilitates its proteasomal degradation. This effect was specific to PYK2 inhibition and was not obtained by inhibition of FAK. Destabilization of TAZ was associated with profound effect of PYK2 inhibition on cell growth at low-density concomitant with reduced expression of TAZ-target genes and induction of cell apoptosis. We further show that PYK2 enhances the tyrosine phosphorylation of both TAZ and LATS1/2 and concomitantly TAZ stability, and that PYK2 protein level correlates with the level of TAZ protein in primary breast tumors. Together these observations suggest that PYK2 is an important regulator of the Hippo pathway, and its tyrosine kinase activity has a striking effect on TAZ stabilization and activation in TNBC.

摘要

肿瘤抑制因子 Hippo 通路通过负调控转录共激活因子 Yes 相关蛋白(YAP)和 PDZ 结合基序转录共激活因子(TAZ)来抑制细胞生长和控制器官大小,而 YAP 和 TAZ 的激活与肿瘤发生和癌症转移有关。在这里,我们报告非受体酪氨酸激酶 PYK2 在三阴性乳腺癌(TNBC)中正向调节 TAZ 和 YAP 的转录活性。我们发现抑制 PYK2 的表达或其激酶活性显著影响 TAZ 的稳定状态,并显著促进其蛋白酶体降解。这种效应是 PYK2 抑制所特有的,而不是通过抑制 FAK 获得的。TAZ 的不稳定与 PYK2 抑制在低密度时对细胞生长的深刻影响有关,同时伴随着 TAZ 靶基因表达的降低和细胞凋亡的诱导。我们进一步表明,PYK2 增强了 TAZ 和 LATS1/2 的酪氨酸磷酸化,同时也增强了 TAZ 的稳定性,并且 PYK2 蛋白水平与原发性乳腺癌肿瘤中 TAZ 蛋白的水平相关。综上所述,这些观察结果表明 PYK2 是 Hippo 通路的一个重要调节因子,其酪氨酸激酶活性对 TNBC 中 TAZ 的稳定和激活有显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/ab12bc101070/41419_2018_1005_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/448f0787f35f/41419_2018_1005_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/916a684d7a38/41419_2018_1005_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/16b42535bd9f/41419_2018_1005_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/869f001df439/41419_2018_1005_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/c31bd8b6d5e4/41419_2018_1005_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/80e82c57bd38/41419_2018_1005_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/ab12bc101070/41419_2018_1005_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/448f0787f35f/41419_2018_1005_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/916a684d7a38/41419_2018_1005_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/16b42535bd9f/41419_2018_1005_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/869f001df439/41419_2018_1005_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/c31bd8b6d5e4/41419_2018_1005_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/80e82c57bd38/41419_2018_1005_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/6155151/ab12bc101070/41419_2018_1005_Fig7_HTML.jpg

相似文献

1
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein.PYK2 通过稳定 TAZ 蛋白负调控三阴性乳腺癌中的 Hippo 通路。
Cell Death Dis. 2018 Sep 24;9(10):985. doi: 10.1038/s41419-018-1005-z.
2
The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.非受体酪氨酸激酶 c-Src 减弱了 SCF(β-TrCP) E3 连接酶的活性,从而阻止了 Taz 的蛋白酶体降解。
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1678-1683. doi: 10.1073/pnas.1610223114. Epub 2017 Feb 1.
3
Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.Hippo 通路与小分子 GTP 酶通路对 YAP/TAZ 的相互调控。
Small GTPases. 2020 Jul;11(4):280-288. doi: 10.1080/21541248.2018.1435986. Epub 2018 Apr 20.
4
A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.一种YAP/TAZ诱导的反馈机制调节Hippo信号通路的稳态。
Genes Dev. 2015 Jun 15;29(12):1271-84. doi: 10.1101/gad.262816.115.
5
Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.Ski通过调节Hippo和TAZ信号通路来抑制乳腺癌进展。
Sci Signal. 2015 Feb 10;8(363):ra14. doi: 10.1126/scisignal.2005735.
6
TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.在哺乳动物细胞中,TAZ蛋白的积累受到YAP丰度的负调控。
J Biol Chem. 2015 Nov 13;290(46):27928-38. doi: 10.1074/jbc.M115.692285. Epub 2015 Oct 2.
7
The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC.三阴性乳腺癌中干性维持相关环路的 AXL-PYK2-PKCα 轴。
Life Sci Alliance. 2021 Mar 30;4(6). doi: 10.26508/lsa.202000985. Print 2021 Jun.
8
Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.鞘氨醇磷酸胆碱以双重方式调节Hippo信号通路。
Cell Signal. 2016 Dec;28(12):1894-1903. doi: 10.1016/j.cellsig.2016.09.004. Epub 2016 Sep 12.
9
Synaptopodin-2 suppresses metastasis of triple-negative breast cancer via inhibition of YAP/TAZ activity.突触足蛋白-2通过抑制YAP/TAZ活性抑制三阴性乳腺癌的转移。
J Pathol. 2018 Jan;244(1):71-83. doi: 10.1002/path.4995.
10
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.原癌基因 SRC 激酶激活 YAP/TAZ 轴,从而驱动肿瘤生长和转移。
J Biol Chem. 2019 Feb 15;294(7):2302-2317. doi: 10.1074/jbc.RA118.004364. Epub 2018 Dec 17.

引用本文的文献

1
Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.整合素 αVβ1 激活的 PYK2 通过 STAT3-VGF 轴促进非小细胞肺癌的进展。
Cell Commun Signal. 2024 Jun 6;22(1):313. doi: 10.1186/s12964-024-01639-1.
2
The Hippo pathway terminal effector TAZ/WWTR1 mediates oxaliplatin sensitivity in p53 proficient colon cancer cells. Hippo 通路终末效应物 TAZ/WWTR1 介导 p53 功能正常的结肠癌细胞对奥沙利铂的敏感性。
BMC Cancer. 2024 May 14;24(1):587. doi: 10.1186/s12885-024-12316-4.
3
Enhancing the productivity and proliferation of CHO-K1 cells by oncoprotein YAP (Yes-associated protein).

本文引用的文献

1
Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.Src 通过酪氨酸磷酸化 Lats1 抑制 Hippo 肿瘤抑制通路。
Cancer Res. 2017 Sep 15;77(18):4868-4880. doi: 10.1158/0008-5472.CAN-17-0391. Epub 2017 Jul 28.
2
The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.非受体酪氨酸激酶 c-Src 减弱了 SCF(β-TrCP) E3 连接酶的活性,从而阻止了 Taz 的蛋白酶体降解。
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1678-1683. doi: 10.1073/pnas.1610223114. Epub 2017 Feb 1.
3
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis.
通过癌蛋白 YAP(Yes 相关蛋白)提高 CHO-K1 细胞的生产力和增殖能力。
Appl Microbiol Biotechnol. 2024 Apr 4;108(1):285. doi: 10.1007/s00253-024-13122-5.
4
E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies.E3 泛素连接酶和去泛素化酶在膀胱癌发生中的作用及其对免疫治疗的影响。
Front Immunol. 2023 Jul 11;14:1226057. doi: 10.3389/fimmu.2023.1226057. eCollection 2023.
5
Transcriptomic Analysis of Subtype-Specific Tyrosine Kinases as Triple Negative Breast Cancer Biomarkers.作为三阴性乳腺癌生物标志物的亚型特异性酪氨酸激酶的转录组学分析
Cancers (Basel). 2023 Jan 7;15(2):403. doi: 10.3390/cancers15020403.
6
HERC3 promotes YAP/TAZ stability and tumorigenesis independently of its ubiquitin ligase activity.HERC3 独立于其泛素连接酶活性促进 YAP/TAZ 的稳定性和肿瘤发生。
EMBO J. 2023 Feb 15;42(4):e111549. doi: 10.15252/embj.2022111549. Epub 2023 Jan 4.
7
Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1-TAZ Signaling Pathway.华蟾素注射液通过Pin1-TAZ信号通路抑制三阴性乳腺癌的增殖。
Front Pharmacol. 2022 Apr 5;13:797873. doi: 10.3389/fphar.2022.797873. eCollection 2022.
8
USP26 promotes anaplastic thyroid cancer progression by stabilizing TAZ.USP26 通过稳定 TAZ 促进甲状腺未分化癌的进展。
Cell Death Dis. 2022 Apr 9;13(4):326. doi: 10.1038/s41419-022-04781-1.
9
L-plastin enhances NLRP3 inflammasome assembly and bleomycin-induced lung fibrosis.L-肌动蛋白增强 NLRP3 炎症小体组装和博来霉素诱导的肺纤维化。
Cell Rep. 2022 Mar 15;38(11):110507. doi: 10.1016/j.celrep.2022.110507.
10
Regulation of Gene Expression by Telomere Position Effect.端粒位置效应调控基因表达。
Int J Mol Sci. 2021 Nov 26;22(23):12807. doi: 10.3390/ijms222312807.
靶向 PYK2 与表皮生长因子受体拮抗剂联合作用于基底样三阴性乳腺癌,并通过 NEDD4-NDRG1 轴规避 HER3 相关耐药性。
Cancer Res. 2017 Jan 1;77(1):86-99. doi: 10.1158/0008-5472.CAN-16-1797. Epub 2016 Oct 28.
4
Phosphorylation of Tyr188 in the WW domain of YAP1 plays an essential role in YAP1-induced cellular transformation.YAP1的WW结构域中酪氨酸188的磷酸化在YAP1诱导的细胞转化中起关键作用。
Cell Cycle. 2016 Sep 16;15(18):2497-505. doi: 10.1080/15384101.2016.1207836. Epub 2016 Jul 18.
5
Knockdown of TAZ modifies triple-negative breast cancer cell sensitivity to EGFR inhibitors by regulating YAP expression.敲低TAZ可通过调节YAP表达来改变三阴性乳腺癌细胞对表皮生长因子受体(EGFR)抑制剂的敏感性。
Oncol Rep. 2016 Aug;36(2):729-36. doi: 10.3892/or.2016.4875. Epub 2016 Jun 15.
6
The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair.MST/河马通路与细胞死亡:一种非典型关系。
Genes (Basel). 2016 Jun 17;7(6):28. doi: 10.3390/genes7060028.
7
YAP/TAZ at the Roots of Cancer.YAP/TAZ与癌症根源
Cancer Cell. 2016 Jun 13;29(6):783-803. doi: 10.1016/j.ccell.2016.05.005.
8
Mechanisms of Hippo pathway regulation.河马通路的调控机制。
Genes Dev. 2016 Jan 1;30(1):1-17. doi: 10.1101/gad.274027.115.
9
YAP enhances the pro-proliferative transcriptional activity of mutant p53 proteins.YAP增强了突变型p53蛋白的促增殖转录活性。
EMBO Rep. 2016 Feb;17(2):188-201. doi: 10.15252/embr.201540488. Epub 2015 Dec 21.
10
Expression of Yes-associated protein (YAP) in metastatic breast cancer.Yes相关蛋白(YAP)在转移性乳腺癌中的表达。
Int J Clin Exp Pathol. 2015 Sep 1;8(9):11248-57. eCollection 2015.